Dr. Jacob Teitelbaum is one of the most frequently quoted integrative medical authorities in the world. He is the author of the best-selling From Fatigued to Fantastic!, Diabetes Is Optional, Pain Free, 1,2,3!, the Beat Sugar Addiction Now! series, Real Cause Real Cure, The Fatigue and Fibromyalgia Solution, and the popular free smartphone app Cures A-Z. He is the lead author of seven studies on effective treatment for fibromyalgia and chronic fatigue syndrome (including one with ginseng), and a study on effective treatment of autism using NAET. Dr. Teitelbaum is a member of the Scientific Advisory Board of EuroMedica, a company that specializes in offering a wide range of herbal and nutritional supplements to health care professionals, including specialized red ginseng (HRG80). He appears often as a guest on news and talk shows nationwide including "Good Morning America," "The Dr. Oz Show," "Oprah & Friends," CNN, and Fox News Health. Learn more at Vitality101.com.
In the tradition of the Five Elements, the spirit leads us to the source of function or dysfunction. As a pelvic health specialist, I have found that the spirit of the points on the pelvis are particularly important in supporting our clients, as they connect deeply with the spirit. Working with the points on the pelvis is often pivotal for the client and thus requires a well-designed foundation.
To plateau and profit or release and replace is an ethical dilemma we clinicians will face sometime during our career. In work situations in which oversight ranges from limited to excessive, we navigate our practices, businesses and/or positions between the poles of profit and loss, moral and legal. The question is: What do we do when the patient's clinical progress becomes stagnant, yet they will freely continue to receive treatment?
| Digital Exclusive
Long COVID has challenged conventional medical paradigms. There is certainly a growing need for therapies that bridge traditional pharmacology with integrative strategies. Among the more unconventional options, nicotine – delivered via low-dose transdermal patches – has surfaced as a potential tool. While the idea may sound wacky, emerging evidence and clinical anecdotes suggest it warrants exploration.
